Anti Diabetes, Weight Loss Drug Also Reduces Cancer!
Next-generation anti-diabetes drug tirzepa-tide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced obesity-asso-ciated breast cancer growths in recent mouse-based experiments… Researchers say there’s potential for similar results in humans!Read More →








